IDiyas

For the Inventor, By the Inventor

Montvale, NJ, United States of America

Joseph P Joseph

USPTO Granted Patents = 26

Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 229(Granted Patents)


Location History:

  • Cliffside Park, NJ (US) (1977 - 1981)
  • Montvale, NJ (US) (1980 - 1990)
  • Montvale, NY (US) (1993)

Company Filing History:

goldMedal26 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1977-1993

Loading Chart...
26 patents (USPTO):Explore Patents
1. 5210193 - Piperazine derivatives (1993-05-11),
2. 4940710 - 7-(substituted)piperaziny (1990-07-10),
3. 4622401 - Heterocyclic substituted-amino-pyrazolines (1986-11-11),
4. 4451479 - Therapeutically active 3-amino-1-halogenated phenyl-2-pyrazolines and (1984-05-29),
5. 4448973 - Therapeutically active 3-substituted amino-1-phenyl and substituted (1984-05-15),
6. 4447442 - 3-Trifluoroacetylamino-1-aryl-2-pyrazolines (1984-05-08),
7. 4432991 - Therapeutically active 3-amino-1-phenyl(and substituted (1984-02-21),
8. 4393055 - Hydroxyalkyl ether derivatives of rutin poly(H-)sulfate and method of use (1983-07-12),
9. 4376122 - Novel 3-substituted amino-1-heteroaryl-2-pyrazolines (1983-03-08),
10. 4374832 - Modulators of the complement system comprising polyhexaose arylene (1983-02-22),
11. 4374831 - Modulators of the complement system comprising bis-glucopyranosyl (1983-02-22),
12. 4360680 - Therapeutically active 3-amino-1-phenyl and substituted (1982-11-23),
13. 4359458 - O-.beta.. -D (and O-.alpha... -D) Multigalactopyranosyl, xylopyranosyl (1982-11-16),
14. 4357326 - Multi-glucopyranosyl-fructofuranosyl-galactopyranosyl-glucopyranoside (1982-11-02),
15. 4348527 - 3-Trifluoroacetyl amino-1-aryl-2-pyrazolines (1982-09-07),

Title: Joseph P Joseph: Innovator in the Pharmaceutical Field

Introduction

Joseph P Joseph, a prominent inventor based in Montvale, NJ, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 26 patents, he has been pivotal in developing innovative treatments for bacterial infections in warm-blooded animals.

Latest Patents

Among his latest innovations are the patents for piperazine derivatives, specifically 7-(substituted)piperazinyl-1-ethyl-6-fluoro-4-oxo-3-quinolinecarboxylic acids and their pharmacologically acceptable salts. These compositions include processes and intermediates for production, as well as methods for treating bacterial infections, showcasing his dedication to improving health outcomes through innovative chemistry.

Career Highlights

Joseph is currently associated with American Cyanamid Company, where he collaborates on various research projects aimed at advancing pharmaceutical sciences. His extensive experience and deep understanding of chemical compounds have played a crucial role in his success as an inventor.

Collaborations

Working alongside talented colleagues such as Seymour Bernstein and Vijay G Nair, Joseph has fostered an environment of creativity and innovation. Their collaborative efforts have not only led to impressive patent filings but also contributed to the overall advancement of pharmaceutical technologies.

Conclusion

Joseph P Joseph's commitment to innovation is evident through his numerous patents and collaborative spirit. His contributions to the pharmaceutical industry highlight the importance of research and development in creating effective treatments for bacterial infections, marking him as a key figure in modern science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…